SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-288539
Filing Date
2020-11-09
Accepted
2020-11-09 08:14:02
Documents
14
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d798228d8k.htm   iXBRL 8-K 25985
2 EX-99.1 d798228dex991.htm EX-99.1 96566
6 GRAPHIC g798228g1107065416695.jpg GRAPHIC 8440
  Complete submission text file 0001193125-20-288539.txt   270195

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bstc-20201109.xsd EX-101.SCH 3069
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20201109_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20201109_pre.xml EX-101.PRE 11407
7 EXTRACTED XBRL INSTANCE DOCUMENT d798228d8k_htm.xml XML 3423
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34236 | Film No.: 201296207
SIC: 2834 Pharmaceutical Preparations